Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$293,531
-31.81%
Shares
Shares Volume: 10,420 Shares
Average Share Price: $28.17
INSIDER
Ballal Rahul D.
(Director)
reported on Oct 10 2024
traded on Oct 8 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 22,341 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $451,393.52 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 5 |
| PURCHASES/SALES 1Y | 0 / 90 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $895,149.26 |
| COMPANY PREVIOUS TRADES |